Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
Read the full article on CNBC
Read Full Article →